Home
>
National Drug Code (NDC)
>
Theophylline
Theophylline - 50111-459-02 - (Theophylline)
Drug Information of Theophylline
| Product NDC: | 50111-459 |
| Proprietary Name: | Theophylline |
| Non Proprietary Name: | Theophylline |
| Active Ingredient(s): | 300 mg/1 & nbsp; Theophylline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Theophylline
| Product NDC: | 50111-459 |
| Labeler Name: | Pliva Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA089763 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19900930 |
Package Information of Theophylline
| Package NDC: | 50111-459-02 |
| Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50111-459-02) |
NDC Information of Theophylline
| NDC Code | 50111-459-02 |
| Proprietary Name | Theophylline |
| Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (50111-459-02) |
| Product NDC | 50111-459 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Theophylline |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 19900930 |
| Marketing Category Name | ANDA |
| Labeler Name | Pliva Inc. |
| Substance Name | THEOPHYLLINE ANHYDROUS |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |
